Fachnews | Arzneimittel

Additional benefit assessment: AMNOG portal now also available in English

Berlin, 30th August 2022 - The Federal Joint Committee (G-BA) now also offers pharmaceutical companies an English-language version of its ”AMNOG-Portal” for submitting documents on the benefit assessment procedures according to Section 35a of the German Social Code, Book V (SGB V). Pharmaceutical companies can use the portal to submit all procedural documents electronically, such as applications for advice, dossiers, statements or documents on the data collection accompanying the application.The basic requirements from the Rules of Procedure, which documents must be submitted in German and which can be submitted in English, do not change with this.

The “AMNOG-Portal” can be reached at: https://extern.portal.g-ba.de/

For the English version please select „English“ in the top right corner of the page.

The notification was updated on 6 September 2022.


Weiterführende Informationen

For further information on dossier submissions for pharmaceutical companies please visit our website: https://www.g-ba.de/english/benefitassessment/